These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 15849513)

  • 21. Liver metastases of neuroendocrine carcinomas: interventional treatment via transarterial embolization, chemoembolization and thermal ablation.
    Vogl TJ; Naguib NN; Zangos S; Eichler K; Hedayati A; Nour-Eldin NE
    Eur J Radiol; 2009 Dec; 72(3):517-28. PubMed ID: 18829195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trans-catheter arterial chemoembolization as first-line treatment for hepatic metastases from endocrine tumors.
    Roche A; Girish BV; de Baère T; Baudin E; Boige V; Elias D; Lasser P; Schlumberger M; Ducreux M
    Eur Radiol; 2003 Jan; 13(1):136-40. PubMed ID: 12541121
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Percutaneous radiofrequency ablation of hepatic metastases for symptomatic relief of neuroendocrine syndromes.
    Henn AR; Levine EA; McNulty W; Zagoria RJ
    AJR Am J Roentgenol; 2003 Oct; 181(4):1005-10. PubMed ID: 14500219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Repeat transarterial chemoembolization (TACE) for progressive hepatic carcinoid metastases provides results similar to first TACE.
    Varker KA; Martin EW; Klemanski D; Palmer B; Shah MH; Bloomston M
    J Gastrointest Surg; 2007 Dec; 11(12):1680-5. PubMed ID: 17899303
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surgical management of non-colorectal hepatic metastasis.
    Tan MC; Jarnagin WR
    J Surg Oncol; 2014 Jan; 109(1):8-13. PubMed ID: 24122371
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Initial Treatment of Unresectable Neuroendocrine Tumor Liver Metastases with Transarterial Chemoembolization using Streptozotocin: A 20-Year Experience.
    Dhir M; Shrestha R; Steel JL; Marsh JW; Tsung A; Tublin ME; Amesur NB; Orons PD; Santos E; Geller DA
    Ann Surg Oncol; 2017 Feb; 24(2):450-459. PubMed ID: 27663565
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Percutaneous thermal ablation combined with TACE versus TACE monotherapy in the treatment for liver cancer with hepatic vein tumor thrombus: A retrospective study.
    Wang Y; Ma L; Yuan Z; Zheng J; Li W
    PLoS One; 2018; 13(7):e0201525. PubMed ID: 30063737
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transarterial Chemoembolization for Metastatic Neuroendocrine Tumors With Massive Hepatic Tumor Burden: Is the Benefit Worth the Risk?
    Kitano M; Davidson GW; Shirley LA; Schmidt CR; Guy GE; Khabiri H; Dowell JD; Shah MH; Bloomston M
    Ann Surg Oncol; 2016 Nov; 23(12):4008-4015. PubMed ID: 27393568
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined hepatic arterial embolization and hepatic ablation for unresectable colorectal metastases to the liver.
    Fong ZV; Palazzo F; Needleman L; Brown DB; Eschelman DJ; Chojnacki KA; Yeo CJ; Rosato EL
    Am Surg; 2012 Nov; 78(11):1243-8. PubMed ID: 23089443
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective hepatic arterial chemoembolization for liver metastases in patients with carcinoid tumor or islet cell carcinoma.
    Kim YH; Ajani JA; Carrasco CH; Dumas P; Richli W; Lawrence D; Chuang V; Wallace S
    Cancer Invest; 1999; 17(7):474-8. PubMed ID: 10518191
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Diagnosis and treatment of primary hepatic neuroendocrine carcinoma].
    Xu K; Chen Y; Chen M; Zhang W; Wang Y; Ji W; Wang H; Xin X; Feng J; Li Y; Yan L
    Zhonghua Zhong Liu Za Zhi; 2015 Jun; 37(6):451-5. PubMed ID: 26463150
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transarterial chemoembolization of advanced liver metastases of neuroendocrine tumors--a retrospective single-center analysis.
    Kress O; Wagner HJ; Wied M; Klose KJ; Arnold R; Alfke H
    Digestion; 2003; 68(2-3):94-101. PubMed ID: 14593235
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatic neuroendocrine metastases: chemo- or bland embolization?
    Pitt SC; Knuth J; Keily JM; McDermott JC; Weber SM; Chen H; Rilling WS; Quebbeman EJ; Agarwal DM; Pitt HA
    J Gastrointest Surg; 2008 Nov; 12(11):1951-60. PubMed ID: 18709512
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pancreatic carcinoid: transcatheter arterial chemoembolization of liver metastases.
    Gunji N; Miyamoto H; Orii K; Kawamoto T; Fukao K
    Hepatogastroenterology; 2003; 50(54):2166-8. PubMed ID: 14696488
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatic artery embolotherapy of hepatic metastases from carcinoid tumors: value of using a mixture of cyanoacrylate and ethiodized oil.
    Winkelbauer FW; Niederle B; Pietschmann F; Thurnher S; Wildling R; Prokesch R; Lammer J
    AJR Am J Roentgenol; 1995 Aug; 165(2):323-7. PubMed ID: 7542430
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surgical therapy of liver metastases.
    Kuvshinoff B; Fong Y
    Semin Oncol; 2007 Jun; 34(3):177-85. PubMed ID: 17560979
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Laparoscopic radiofrequency ablation of neuroendocrine liver metastases: a 10-year experience evaluating predictors of survival.
    Mazzaglia PJ; Berber E; Milas M; Siperstein AE
    Surgery; 2007 Jul; 142(1):10-9. PubMed ID: 17629995
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical features and outcomes of primary hepatic neuroendocrine carcinomas.
    Park CH; Chung JW; Jang SJ; Chung MJ; Bang S; Park SW; Song SY; Chung JB; Park JY
    J Gastroenterol Hepatol; 2012 Aug; 27(8):1306-11. PubMed ID: 22414232
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transarterial chemoembolization of unresectable systemic chemotherapy-refractory liver metastases from colorectal cancer: long-term results over a 10-year period.
    Gruber-Rouh T; Naguib NN; Eichler K; Ackermann H; Zangos S; Trojan J; Beeres M; Harth M; Schulz B; Nour-Eldin A NE; Vogl TJ
    Int J Cancer; 2014 Mar; 134(5):1225-31. PubMed ID: 23960002
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liver-directed therapy for hepatic metastases in patients undergoing pancreaticoduodenectomy: a dual-center analysis.
    De Jong MC; Farnell MB; Sclabas G; Cunningham SC; Cameron JL; Geschwind JF; Wolfgang CL; Herman JM; Edil BH; Choti MA; Schulick RD; Nagorney DM; Pawlik TM
    Ann Surg; 2010 Jul; 252(1):142-8. PubMed ID: 20531007
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.